恆新豐控股(01920.HK)中期收益同比減少約29.6%至4390萬港元
格隆匯8月26日丨恆新豐控股(01920.HK)公吿,截至2022年6月30日止6個月中期,集團的收益同比減少約29.6%至約4390萬港元。集團報吿於回顧期間公司擁有人應占虧損約為3470萬港元,而截至2021年6月30日止6個月的淨虧損則約為1000萬港元。每股虧損1.31港仙。董事會不建議就回顧期間派付中期股息(截至2021年6月30日止6個月:無)。
收益減少乃主要由於(i)回顧期間手頭項目大致竣工,而且市場競爭激烈導致建築項目定價需具競爭力;及(ii)有關客户延遲對本集團若干已完成工程進行認證,此乃由於已完成的工程涉及有關項目的多個訂單變更,故有關客户需要額外時間進行認證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.